Skip to content

News Releases

Listing will update automatically when filter selections change

416 Results

May 17, 2025

Study Explores Mentions of Substance Use, Mental Health in Pop Music Since 2013

New research presented today at the American Psychiatric Association’s Annual Meeting examines trends in the way popular music reflects national trends in substance use and mental health. Because of their cultural impact, pop songs shape how substance use is discussed and can potentially serve as an important public health tool to help reduce stigma and promote healthy habits.

May 17, 2025

APA Gives Back to FEAST

uring the Opening Session of its 2025 Annual Meeting today, the American Psychiatric Association (APA) presented a donation of $26,248 to the nonprofit organization FEAST. FEAST (which stands for Food, Education, Access, Support, Together) advances health equity through nutrition education, food access, and socioemotional support for individuals and families experiencing food insecurity.

May 15, 2025

Encuesta anual sobre salud mental revela que los estadounidenses están preocupados por los acontecimientos actuales; 40% de trabajadores se preocupan por la seguridad de su empleo

  • Español

Antes de la reunión anual de la Asociación Psiquiátrica Americana (APA) en Los Ángeles, la organización ha publicado hoy los datos de una encuesta que revelan que dos tercios de los estadounidenses están ansiosos por los últimos acontecimientos que suceden en todo el mundo. La encuesta también informa sobre las actitudes hacia la salud mental y las fuentes de ansiedad relacionadas con el trabajo

March 27, 2025

APA Publishing Expands Its Digital Books Collection

American Psychiatric Association (APA) Publishing has launched an extensive digital back catalog of hundreds of books from the past 40 years for clinicians, mental health professionals, residents, researchers, and students in psychiatry and allied disciplines

March 21, 2025

Joint Statement on Federal Concerns About Psychotropic Medication Safety

The safety and efficacy of traditional antidepressants, antipsychotics, and mood stabilizers (such as lithium and some anticonvulsants) and stimulant medications have been established through decades of rigorous research, randomized clinical trials, peer-reviewed studies, meta-analyses, national registry studies of thousands of people, post-marketing pharmacovigilance monitoring, and FDA oversight.

Medical leadership for mind, brain and body.

Join Today